12:00 AM
 | 
Dec 12, 2011
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Atossa Genetics sales and marketing update

Atossa launched its ForeCYTE Breast Health Test to a select group of customers in the U.S. The diagnostic differentiates between normal, premalignant and malignant tumor...

Read the full 114 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >